BNY Mellon Sm/Md Cp Gr Z holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
BNY Mellon Small/Mid Cap Growth Fund Class Z DBMZX
- NAV / 1-Day Return 23.56 / 0.00
- Total Assets 817.3M
-
Adj. Expense Ratio
0.880%
- Expense Ratio 0.830%
- Distribution Fee Level Above Average
- Share Class Type Institutional
- Category Mid-Cap Growth
- Investment Style Small Growth
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 131%
USD | NAV as of Jul 16, 2026 | 1-Day Return as of Jul 16, 2026, 12:11 AM GMT+0
Morningstar’s Analysis DBMZX
Will DBMZX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 29.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Guardant Health Inc | 4.42 | 36M | Healthcare |
Repligen Corp | 3.46 | 28M | Healthcare |
The Baldwin Insurance Group Inc Class A | 3.30 | 27M | Financial Services |
MKS Inc | 3.23 | 26M | Technology |
Construction Partners Inc Class A | 3.18 | 26M | Industrials |
Curtiss-Wright Corp | 2.88 | 23M | Industrials |
Herc Holdings Inc | 2.65 | 22M | Industrials |
Wingstop Inc | 2.65 | 22M | Consumer Cyclical |
Bel Fuse Inc Class B | 2.64 | 22M | Technology |
Casey's General Stores Inc | 2.64 | 22M | Consumer Cyclical |